Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans. - Lim TY; Perpiñán E; Londoño MC; Miquel R; Ruiz P; Kurt AS; Kodela E; Cross AR; Berlin C; Hester J; Issa F; Douiri A; et al. (Journal of hepatology, 2023)